Transformation of Luneau Technology delivers MML a return of 2.1x

MML has successfully exited its investment in Luneau Technology, a global leader in ophthalmological diagnostic equipment, refractive optometry equipment and equipment for opticians. The Group directly operates in 11 countries, with partners in more than 75 countries, selling its products worldwide.

A new step for Luneau Technology

MML Capital Partners has invested into The Luneau Technology Group (“Luneau”). Luneau is a world leader in the supply of diagnostic equipment, analysis and testing in ophthalmology, refractive optometry equipment and cutting equipment and mounting opticians. Luneau operates in 9 countries, and sells into over 100.

MML investor portal logins

For investors in MML Fund VI, MML Ireland I & MML Ireland II

For investors in MML Fund VII